Pharmacokinetics of cannabinoids.

  title={Pharmacokinetics of cannabinoids.},
  author={I J Mcgilveray},
  journal={Pain research & management},
  volume={10 Suppl A},
Delta-9-tetrahydrocannabinol (Delta-9-THC) is the main psychoactive ingredient of cannabis (marijuana). The present review focuses on the pharmacokinetics of THC, but also includes known information for cannabinol and cannabidiol, as well as the synthetic marketed cannabinoids, dronabinol (synthetic THC) and nabilone. The variability of THC in plant material (0.3% to 30%) leads to variability in tissue THC levels from smoking, which is, in itself, a highly individual process. THC… CONTINUE READING
Highly Cited
This paper has 53 citations. REVIEW CITATIONS


Publications citing this paper.
Showing 1-10 of 30 extracted citations

Large Amount of Cannabis Ingestion Resulting in Spontaneous Intracerebral Hemorrhage: A Case Report.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association • 2017

53 Citations

Citations per Year
Semantic Scholar estimates that this publication has 53 citations based on the available data.

See our FAQ for additional information.


Publications referenced by this paper.
Showing 1-10 of 65 references

Qualitative and quantitative analysis of the cannabinoid content of combusted plant tissue

A Jack, G. McKay
Canadian Society for Pharmaceutical Sciences, 7th annual symposium, • 2004

Pharmacokinetics and pharmacodynamics of cannabinoids.

Clinical pharmacokinetics • 2003
View 2 Excerpts

Absorption, distribution and biotransformation of the cannabinoids

DJ Harvey
Agurell S, eds. Marihuana and Medicine. Totowa, • 1999

Cannabinoid geometry and biological activity

R Mechoulam, WA Devane, R. Glaser
Agurell S, eds. Marihuana and Medicine. Totowa, • 1999
View 2 Excerpts

Chemistry and pharmacology of cannabis

BR Martin, EJ Cone
The Health Effects of Cannabis. Toronto: Centre for Addiction and Mental Health, • 1999